These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29710219)

  • 1. Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee.
    McCoy MS; Pagán O; Donohoe G; Kanter GP; Litman RS
    JAMA Intern Med; 2018 Jul; 178(7):996-997. PubMed ID: 29710219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
    Roberts W; Jellison S; Wayant C; Vassar M
    BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):MR000040. PubMed ID: 33289919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is a point of view a conflict of interest?
    Lenzer J
    BMJ; 2016 Nov; 355():i6194. PubMed ID: 27881367
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflicts cause FDA to review advisory committees.
    Kondro W
    CMAJ; 2006 Jul; 175(1):23. PubMed ID: 16818900
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration.
    Abola MV; Prasad V
    JAMA Intern Med; 2016 Mar; 176(3):389-91. PubMed ID: 26831527
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
    Hayes MJ; Prasad V
    Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.
    Lammers A; Edmiston J; Kaestner V; Prasad V
    Mayo Clin Proc; 2017 Jul; 92(7):1164-1166. PubMed ID: 28688469
    [No Abstract]   [Full Text] [Related]  

  • 11. Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings.
    McCoy MS; Emanuel EJ
    Nat Rev Clin Oncol; 2016 May; 13(5):267-8. PubMed ID: 27071349
    [No Abstract]   [Full Text] [Related]  

  • 12. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA needs a more "nuanced" approach to advisers' conflicts of interest, researchers say.
    Dyer O
    BMJ; 2014 Sep; 349():g5665. PubMed ID: 25227397
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflicts of interest in pain medicine: Practice patterns and relationships with industry.
    Schofferman J; Banja J
    Pain; 2008 Oct; 139(3):494-497. PubMed ID: 18814969
    [No Abstract]   [Full Text] [Related]  

  • 15. Public Speaker Characteristics at Meetings of the Dermatologic and Ophthalmic Drug Advisory Committee and the Ophthalmic Devices Panel.
    Khattab MH; Weaver M; Cook C; Kinder N; Vassar M
    Am J Ophthalmol; 2021 Mar; 223():28-32. PubMed ID: 33166500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US dietary committee criticised for ties to industry.
    Nelson R
    Lancet; 2003 Sep; 362(9386):808. PubMed ID: 13678891
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial conflicts of interest during meetings of the cardiovascular and renal drugs advisory committee.
    Bertolino B; Kinder N; Cooper C; Gray H; Arthur W; Ahlander J; Simpson A; Vassar M
    J Osteopath Med; 2022 Sep; 122(9):445-451. PubMed ID: 35447023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US advisory panellists on drug's safety had ties to manufacturers.
    Lenzer J; Epstein K
    BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.